Mold allergens in respiratory allergy: From structure to therapy

Allergy, Asthma and Immunology Research

Volumn 7, Issue 3, 2015, Pages 205-220

  Twaroch, Teresa E ^a   Curin, Mirela ^a   Valenta, Rudolf ^a   Swoboda, Ines ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF APPLIED SCIENCES   (Austria)

Author keywords

Allergen structure; Fungal allergy; Recombinant allergens; Specific immunotherapy

Indexed keywords

ALLERGEN;

ALLERGIC RHINITIS; ALTERNARIA; ALTERNARIA ALTERNATA; AMINO ACID SEQUENCE; ASTHMA; CLADOSPORIUM; CLADOSPORIUM HERBARUM; CROSS REACTION; FUNGAL STRUCTURES; HUMAN; IMMUNOTHERAPY; MYCOSIS; NONHUMAN; PREVALENCE; RESPIRATORY TRACT ALLERGY; REVIEW; SENSITIZATION; SKIN TEST;

EID: 84928993649     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2015.7.3.205     Document Type: Review

References (152)

1. Von Pirquet C. Allergie. Münch Med Wochenschr 1906;53:1457-8.
2. Floyer J. Violent asthma after visiting a wine cellar. In: A treatise on asthma. 3rd ed. London: Innys and Parker; 1726.
3. Blackley CH. Experimental researches on the causes and nature of Catarrhus aestivus, hay fever or hay asthma (1873). London: Bailliere, Tindall and Cox; 1873.
4. Newson R, Strachan D, Corden J, Millington W. Fungal and other spore counts as predictors of admissions for asthma in the Trent region. Occup Environ Med 2000;57:786-92.
5. Crameri R, Garbani M, Rhyner C, Huitema C. Fungi: the neglected allergenic sources. Allergy 2014;69:176-85.
6. Simon-Nobbe B, Denk U, Pöll V, Rid R, Breitenbach M. The spectrum of fungal allergy. Int Arch Allergy Immunol 2008;145:58-86.
7. Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F, et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002;325:411-4.
8. Jo EJ, Kim MY, Lee SE, Lee SY, Kim MH, Song WJ, et al. Eosinophilic airway inflammation and airway hyperresponsiveness according to aeroallergen sensitization pattern in patients with lower airway symptoms. Allergy Asthma Immunol Res 2014;6:39-46.
9. Iossifova YY, Reponen T, Ryan PH, Levin L, Bernstein DI, Lockey JE, et al. Mold exposure during infancy as a predictor of potential asthma development. Ann Allergy Asthma Immunol 2009;102: 131-7.
10. Garrett MH, Rayment PR, Hooper MA, Abramson MJ, Hooper BM. Indoor airborne fungal spores, house dampness and associations with environmental factors and respiratory health in children. Clin Exp Allergy 1998;28:459-67.
11. Nolles G, Hoekstra MO, Schouten JP, Gerritsen J, Kauffman HF. Prevalence of immunoglobulin E for fungi in atopic children. Clin Exp Allergy 2001;31:1564-70.
12. Andriessen JW, Brunekreef B, Roemer W. Home dampness and respiratory health status in european children. Clin Exp Allergy 1998;28:1191-200.
13. Hagmolen of Ten Have W, van den Berg NJ, van der Palen J, van Aalderen WM, Bindels PJ. Residential exposure to mould and dampness is associated with adverse respiratory health. Clin Exp Allergy 2007;37:1827-32.
14. Meng J, Barnes CS, Rosenwasser LJ; Children's Mercy Center for Environmental Health. Identity of the fungal species present in the homes of asthmatic children. Clin Exp Allergy 2012;42:1448-58.
15. Targonski PV, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995;95:955-61.
16. Rodríguez-Rajo FJ, Iglesias I, Jato V. Variation assessment of airborne Alternaria and Cladosporium spores at different bioclimatical conditions. Mycol Res 2005;109:497-507.
17. Hamilton ED. Pollen and fungus spore counts. Proc R Soc Med 1963;56:220-1.
18. Lacey J. Spore dispersal-its role in ecology and disease: the British contribution to fungal aerobiology. Mycol Res 1996;100:641-60.
19. Pulimood TB, Corden JM, Bryden C, Sharples L, Nasser SM. Epidemic asthma and the role of the fungal mold Alternaria alternata. J Allergy Clin Immunol 2007;120:610-7.
20. Hoffman DR, Kozak PP Jr, Gillman SA, Cummins LH, Gallup J. Isolation of spore specific allergens from Alternaria. Ann Allergy 1981;46:310-6.
21. Wahl R, Oliver JD, Hauck PR, Winter HG, Maasch HJ. Comparison of Alternaria tenuis extracts prepared from different raw materials. Ann Allergy 1989;63:527-31.
22. Paris S, Fitting C, Latgé JP, Herman D, Guinnepain MT, David B. Comparison of conidial and mycelial allergens of Alternaria alternata. Int Arch Allergy Appl Immunol 1990;92:1-8.
23. Fadel R, David B, Paris S, Guesdon JL. Alternaria spore and mycelium sensitivity in allergic patients: in vivo and in vitro studies. Ann Allergy 1992;69:329-35.
24. Licorish K, Novey HS, Kozak P, Fairshter RD, Wilson AF. Role of Alternaria and Penicillium spores in the pathogenesis of asthma. J Allergy Clin Immunol 1985;76:819-25.
25. Matsuwaki Y, Uno K, Okushi T, Otori N, Moriyama H. Total and antigen- (fungi, mites and staphylococcal enterotoxins) specific IgEs in nasal polyps is related to local eosinophilic inflammation. Int Arch Allergy Immunol 2013;161 Suppl 2:147-53.
26. Niedoszytko M, Chelminska M, Chelminski K, Knopinska- Posluszny W, Gruchala-Niedoszytko M, Jassem E. Late-phase allergic reaction in nasal provocation with fungal allergens. Allergy Asthma Proc 2008;29:35-9.
27. Paris S, Debeaupuis JP, Prévost MC, Casotto M, Latgé JP. The 31 kd major allergen, Alt a I1563, of Alternaria alternata. J Allergy Clin Immunol 1991;88:902-8.
28. Ibarrola I, Suárez-Cervera M, Arilla MC, Martínez A, Monteseirín J, Conde J, et al. Production profile of the major allergen Alt a 1 in Alternaria alternata cultures. Ann Allergy Asthma Immunol 2004;93: 589-93.
29. Twaroch TE, Arcalís E, Sterflinger K, Stöger E, Swoboda I, Valenta R. Predominant localization of the major Alternaria allergen Alt a 1 in the cell wall of airborne spores. J Allergy Clin Immunol 2012;129: 1148-9.
30. Rivera-Mariani FE, Vysyaraju K, Negherbon J, Levetin E, Horner WE, Hartung T, et al. Comparison of the interleukin-1ß-inducing potency of allergenic spores from higher fungi (basidiomycetes) in a cryopreserved human whole blood system. Int Arch Allergy Immunol 2014;163:154-62.
31. Wada K, Kobayashi T, Matsuwaki Y, Moriyama H, Kita H. Alternaria inhibits double-stranded RNA-induced cytokine production through Toll-like receptor 3. Int Arch Allergy Immunol 2013;161 Suppl 2:75-83.
32. Kim HK, Lund S, Baum R, Rosenthal P, Khorram N, Doherty TA. Innate type 2 response to Alternaria extract enhances ryegrass-induced lung inflammation. Int Arch Allergy Immunol 2014;163:92- 105.
33. D'Amato G, Spieksma FT. Aerobiologic and clinical aspects of mould allergy in Europe. Allergy 1995;50:870-7.
34. Oh SY, Fong JJ, Park MS, Chang L, Lim YW. Identifying airborne fungi in Seoul, Korea using metagenomics. J Microbiol 2014;52: 465-72.
35. Fröhlich-Nowoisky J, Pickersgill DA, Després VR, Pöschl U. High diversity of fungi in air particulate matter. Proc Natl Acad Sci U S A 2009;106:12814-9.
36. Kilic M, Ufuk Altintas D, Yilmaz M, Güneşer Kendirli S, Bingöl Karakoc G, Taskin E, et al. The effects of meteorological factors and Alternaria spore concentrations on children sensitised to Alternaria. Allergol Immunopathol (Madr) 2010;38:122-8.
37. Şakiyan N, Inceoğlu ö. Atmospheric concentrations of Cladosporium link and Alternaria nées spores in ankara and the effects of meteorological factors. Turk J Bot 2003;27:77-81.
38. Bowyer P, Fraczek M, Denning DW. Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope orthologues. BMC Genomics 2006; 7:251.
39. Bernardis P, Agnoletto M, Puccinelli P, Parmiani S, Pozzan M. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 1996;6:55-62.
40. Green BJ, Yli-Panula E, Tovey ER. Halogen immunoassay, a new method for the detection of sensitization to fungal allergens; comparisons with conventional techniques. Allergol Int 2006;55:131-9.
41. Cho SH, Seo SC, Schmechel D, Grinshpun SA, Reponen T. Aerodynamic characteristics and respiratory deposition of fungal fragments. Atmos Environ 2005;39:5454-65.
42. Barnes C, Schreiber K, Pacheco F, Landuyt J, Hu F, Portnoy J. Comparison of outdoor allergenic particles and allergen levels. Ann Allergy Asthma Immunol 2000;84:47-54.
43. Feo Brito F, Alonso AM, Carnés J, Martín-Martín R, Fernández- Caldas E, Galindo PA, et al. Correlation between Alt a 1 levels and clinical symptoms in Alternaria alternata-monosensitized patients. J Investig Allergol Clin Immunol 2012;22:154-9.
44. Mitakakis TZ, Barnes C, Tovey ER. Spore germination increases allergen release from Alternaria. J Allergy Clin Immunol 2001;107: 388-90.
45. Heinzerling L, Frew AJ, Bindslev-Jensen C, Bonini S, Bousquet J, Bresciani M, et al. Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network. Allergy 2005;60:1287-300.
46. Park HJ, Lee JH, Park KH, Ann HW, Jin MN, Choi SY, et al. A nationwide survey of inhalant allergens sensitization and levels of indoor major allergens in Korea. Allergy Asthma Immunol Res 2014; 6:222-7.
47. Lyons TW, Wakefield DB, Cloutier MM. Mold and Alternaria skin test reactivity and asthma in children in Connecticut. Ann Allergy Asthma Immunol 2011;106:301-7.
48. Smit LA, Bouzigon E, Bousquet J, Le Moual N, Nadif R, Pin I, et al. Mold allergen sensitization in adult asthma according to integrin ß3 polymorphisms and Toll-like receptor 2/+596 genotype. J Allergy Clin Immunol 2011;128:185-91.e7.
49. Wiszniewska M, Tymoszuk D, Nowakowska-Świrta E, Palczyński C, Walusiak-Skorupa J. Mould sensitisation among bakers and farmers with work-related respiratory symptoms. Ind Health 2013;51: 275-84.
50. D'Amato G, Chatzigeorgiou G, Corsico R, Gioulekas D, Jäger L, Jäger S, et al. Evaluation of the prevalence of skin prick test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy. A European multicenter study promoted by the Subcommittee on Aerobiology and Environmental Aspects of Inhalant Allergens of the European Academy of Allergology and Clinical Immunology. Allergy 1997;52:711-6.
51. de Benedictis FM, Franceschini F, Hill D, Naspitz C, Simons FE, Wahn U, et al. The allergic sensitization in infants with atopic eczema from different countries. Allergy 2009;64:295-303.
52. Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377-83.
53. Rivera-Mariani FE, Nazario-Jiménez S, López-Malpica F, Bolaños- Rosero B. Skin test reactivity of allergic subjects to basidiomycetes' crude extracts in a tropical environment. Med Mycol 2011;49:887- 91.
54. Mari A, Schneider P, Wally V, Breitenbach M, Simon-Nobbe B. Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts. Clin Exp Allergy 2003;33:1429-38.
55. Niemeijer NR, de Monchy JG. Age-dependency of sensitization to aero-allergens in asthmatics. Allergy 1992;47:431-5.
56. Ezeamuzie CI, Al-Ali S, Khan M, Hijazi Z, Dowaisan A, Thomson MS, et al. IgE-mediated sensitization to mould allergens among patients with allergic respiratory diseases in a desert environment. Int Arch Allergy Immunol 2000;121:300-7.
57. Bartra J, Belmonte J, Torres-Rodriguez JM, Cistero-Bahima A. Sensitization to Alternaria in patients with respiratory allergy. Front Biosci (Landmark Ed) 2009;14:3372-9.
58. Moral L, Roig M, Garde J, Alós A, Toral T, Fuentes MJ. Allergen sensitization in children with asthma and rhinitis: marked variations related to age and microgeographical factors. Allergol Immunopathol (Madr) 2008;36:128-33.
59. Cantani A, Ciaschi V. Epidemiology of alternaria alternata allergy: a prospective study in 6840 Italian asthmatic children. Eur Rev Med Pharmacol Sci 2004;8:289-94.
60. Niederberger V, Stübner P, Spitzauer S, Kraft D, Valenta R, Ehrenberger K, et al. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J Invest Dermatol 2001;117:848-51.
61. Liang KL, Su MC, Jiang RS. Comparison of the skin test and ImmunoCAP system in the evaluation of mold allergy. J Chin Med Assoc 2006;69:3-6.
62. Kespohl S, Maryska S, Zahradnik E, Sander I, Brüning T, Raulf- Heimsoth M. Biochemical and immunological analysis of mould skin prick test solution: current status of standardization. Clin Exp Allergy 2013;43:1286-96.
63. Soeria-Atmadja D, Onell A, Borgå A. IgE sensitization to fungi mirrors fungal phylogenetic systematics. J Allergy Clin Immunol 2010;125:1379-86.e1.
64. Valenta R, Ferreira F, Focke-Tejkl M, Linhart B, Niederberger V, Swoboda I, et al. From allergen genes to allergy vaccines. Annu Rev Immunol 2010;28:211-41.
65. Limacher A, Kloer DP, Flückiger S, Folkers G, Crameri R, Scapozza L. The crystal structure of Aspergillus fumigatus cyclophilin reveals 3D domain swapping of a central element. Structure 2006;14: 185-95.
66. Glaser AG, Limacher A, Flückiger S, Scheynius A, Scapozza L, Crameri R. Analysis of the cross-reactivity and of the 1.5 A crystal structure of the Malassezia sympodialis Mala s 6 allergen, a member of the cyclophilin pan-allergen family. Biochem J 2006;396:41-9.
67. Limacher A, Glaser AG, Meier C, Schmid-Grendelmeier P, Zeller S, Scapozza L, et al. Cross-reactivity and 1.4-A crystal structure of Malassezia sympodialis thioredoxin (Mala s 13), a member of a new pan-allergen family. J Immunol 2007;178:389-96.
68. Nüss D, Goettig P, Magler I, Denk U, Breitenbach M, Schneider PB, et al. Crystal structure of the NADP-dependent mannitol dehydrogenase from Cladosporium herbarum: Implications for oligomerisation and catalysis. Biochimie 2010;92:985-93.
69. Chruszcz M, Chapman MD, Osinski T, Solberg R, Demas M, Porebski PJ, et al. Alternaria alternata allergen Alt a 1: a unique ß-barrel protein dimer found exclusively in fungi. J Allergy Clin Immunol 2012;130:241-7.e9.
70. Wagner GE, Gutfreund S, Fauland K, Keller W, Valenta R, Zangger K. Backbone resonance assignment of Alt a 1, a unique ß-barrel protein and the major allergen of Alternaria alternata. Biomol NMR Assign 2014;8:229-31.
71. Chen JC, Chiu LL, Lee KL, Huang WN, Chuang JG, Liao HK, et al. Identification of critical amino acids in an immunodominant IgE epitope of Pen c 13, a major allergen from Penicillium citrinum. PLoS One 2012;7:e34627.
72. Twaroch TE, Focke M, Fleischmann K, Balic N, Lupinek C, Blatt K, et al. Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy. Clin Exp Allergy 2012;42:966-75.
73. Nair S, Kukreja N, Singh BP, Arora N. Identification of B cell epitopes of alcohol dehydrogenase allergen of Curvularia lunata. PLoS One 2011;6:e20020.
74. Herrera-Mozo I, Ferrer B, Luís Rodriguez-Sanchez J, Juarez C. Description of a novel panallergen of cross-reactivity between moulds and foods. Immunol Invest 2006;35:181-97.
75. Simon-Nobbe B, Probst G, Kajava AV, Oberkofler H, Susani M, Crameri R, et al. IgE-binding epitopes of enolases, a class of highly conserved fungal allergens. J Allergy Clin Immunol 2000;106:887- 95.
76. Chang CY, Chou H, Tam M, Tang RB, Lai HY, Shen HD. Characterization of enolase allergen from Rhodotorula mucilaginosa. J Biomed Sci 2002;9:645-55.
77. Ito K, Ishiguro A, Kanbe T, Tanaka K, Torii S. Detection of IgE antibody against Candida albicans enolase and its crossreactivity to Saccharomyces cerevisiae enolase. Clin Exp Allergy 1995;25:522-8.
78. Flückiger S, Scapozza L, Mayer C, Blaser K, Folkers G, Crameri R. Immunological and structural analysis of IgE-mediated cross-reactivity between manganese superoxide dismutases. Int Arch Allergy Immunol 2002;128:292-303.
79. Horner WE, Reese G, Lehrer SB. Identification of the allergen Psi c 2 from the basidiomycete Psilocybe cubensis as a fungal cyclophilin. Int Arch Allergy Immunol 1995;107:298-300.
80. Flückiger S, Fijten H, Whitley P, Blaser K, Crameri R. Cyclophilins, a new family of cross-reactive allergens. Eur J Immunol 2002;32: 10-7.
81. Shankar J, Gupta PD, Sridhara S, Singh BP, Gaur SN, Arora N. Immunobiochemical analysis of cross-reactive glutathione-S-transferase allergen from different fungal sources. Immunol Invest 2005; 34:37-51.
82. Glaser AG, Menz G, Kirsch AI, Zeller S, Crameri R, Rhyner C. Autoand cross-reactivity to thioredoxin allergens in allergic bronchopulmonary aspergillosis. Allergy 2008;63:1617-23.
83. Chou H, Wu KG, Yeh CC, Tai HY, Tam MF, Chen YS, et al. The transaldolase, a novel allergen of Fusarium proliferatum, demonstrates IgE cross-reactivity with its human analogue. PLoS One 2014;9:e103488.
84. Van Ree R. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol 2002;129:189-97.
85. Altmann F. The role of protein glycosylation in allergy. Int Arch Allergy Immunol 2007;142:99-115.
86. Kobayashi T, Iijima K, Radhakrishnan S, Mehta V, Vassallo R, Lawrence CB, et al. Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol 2009;182:2502-10.
87. Tai HY, Tam MF, Chou H, Peng HJ, Su SN, Perng DW, et al. Pen ch 13 allergen induces secretion of mediators and degradation of occludin protein of human lung epithelial cells. Allergy 2006;61:382- 8.
88. Borger P, Koëter GH, Timmerman JA, Vellenga E, Tomee JF, Kauffman HF. Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms. J Infect Dis 1999;180:1267-74.
89. Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000;105:1185-93.
90. Lamhamedi-Cherradi SE, Martin RE, Ito T, Kheradmand F, Corry DB, Liu YJ, et al. Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12. J Immunol 2008;180:6000-9.
91. Boitano S, Flynn AN, Sherwood CL, Schulz SM, Hoffman J, Gruzinova I, et al. Alternaria alternata serine proteases induce lung inflammation and airway epithelial cell activation via PAR2. Am J Physiol Lung Cell Mol Physiol 2011;300:L605-14.
92. Snelgrove RJ, Gregory LG, Peiró T, Akthar S, Campbell GA, Walker SA, et al. Alternaria-derived serine protease activity drives IL- 33-mediated asthma exacerbations. J Allergy Clin Immunol 2014; 134:583-92.e6.
93. Chen JC, Chuang JG, Su YY, Chiang BL, Lin YS, Chow LP. The protease allergen Pen c 13 induces allergic airway inflammation and changes in epithelial barrier integrity and function in a murine model. J Biol Chem 2011;286:26667-79.
94. Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. III. Diagnosis of Cladosporium allergy by means of symptom score, bronchial provocation test, skin prick test, RAST, CRIE and histamine release. Allergy 1986;41:57-67.
95. Malling HJ, Agrell B, Croner S, Dreborg S, Foucard T, Kjellman M, et al. Diagnosis and immunotherapy of mould allergy. I. Screening for mould allergy. Allergy 1985;40:108-14.
96. Palma-Carlos ML, Palma-Carlos AG. "In vivo" and "in vitro": tests in the diagnosis of trichophyton allergy. Eur Ann Allergy Clin Immunol 2007;39:328-32.
97. Schumacher MJ, Jeffrey SE. Variability of Alternaria alternata: biochemical and immunological characteristics of culture filtrates from seven isolates. J Allergy Clin Immunol 1976;58:263-77.
98. Steringer I, Aukrust L, Einarsson R. Variability of antigenicity/allergenicity in different strains of Alternaria alternata. Int Arch Allergy Appl Immunol 1987;84:190-7.
99. Vijay HM, Young NM, Jackson GE, White GP, Bernstein IL. Studies on Alternaria allergens. V. Comparative biochemical and immunological studies of three isolates of Alternaria tenuis cultured on synthetic media. Int Arch Allergy Appl Immunol 1985;78:37-42.
100. Portnoy J, Pacheco F, Barnes C, Upadrashta B, Crenshaw R, Esch R. Selection of representative Alternaria strain groups on the basis of morphology, enzyme profile, and allergen content. J Allergy Clin Immunol 1993;91:773-82.
101. Martínez J, Gutiérrez A, Postigo I, Cardona G, Guisantes J. Variability of Alt a 1 expression by different strains of Alternaria alternata. J Investig Allergol Clin Immunol 2006;16:279-82.
102. Sáenz-de-Santamaría M, Guisantes JA, Martínez J. Enzymatic activities of Alternaria alternata allergenic extracts and its major allergen (Alt a 1). Mycoses 2006;49:288-92.
103. Marquardt H. Spontaneous mutations in fungi. Humangenetik 1972;16:7-18.
104. Portnoy J, Pacheco F, Ballam Y, Barnes C. The effect of time and extraction buffers on residual protein and allergen content of extracts derived from four strains of Alternaria. J Allergy Clin Immunol 1993;91:930-8.
105. Bisht V, Singh BP, Arora N, Sridhara S, Gaur SN. Allergens of Epicoccum nigrum grown in different media for quality source material. Allergy 2000;55:274-80.
106. Vailes L, Sridhara S, Cromwell O, Weber B, Breitenbach M, Chapman M. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J Allergy Clin Immunol 2001;107:641-6.
107. Brander KA, Borbély P, Crameri R, Pichler WJ, Helbling A. IgEbinding proliferative responses and skin test reactivity to Cop c 1, the first recombinant allergen from the basidiomycete Coprinus comatus. J Allergy Clin Immunol 1999;104:630-6.
108. Hemmann S, Menz G, Ismail C, Blaser K, Crameri R. Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus- sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol 1999;104:601-7.
109. Unger A, Stöger P, Simon-Nobbe B, Susani M, Crameri R, Ebner C, et al. Clinical testing of recombinant allergens of the mold Alternaria alternata. Int Arch Allergy Immunol 1999;118:220-1.
110. Postigo I, Gutiérrez-Rodríguez A, Fernández J, Guisantes JA, Suñén E, Martínez J. Diagnostic value of Alt a 1, fungal enolase and manganese-dependent superoxide dismutase in the componentresolved diagnosis of allergy to Pleosporaceae. Clin Exp Allergy 2011;41:443-51.
111. Katotomichelakis M, Anastassakis K, Gouveris H, Tripsianis G, Paraskakis E, Maroudias N, et al. Clinical significance of Alternaria alternata sensitization in patients with allergic rhinitis. Am J Otolaryngol 2012;33:232-8.
112. Bousquet J, Lockey R, Malling HJ, Alvarez-Cuesta E, Canonica GW, Chapman MD, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81:401-5.
113. Vermani M, Vijayan VK, Kausar MA, Agarwal MK. Quantification of airborne Aspergillus allergens: redefining the approach. J Asthma 2010;47:754-61.
114. Barnes C, Pacheco F, Dhar M, Portnoy J. Alternaria and Cladosporium fungal allergen epitopes are denatured by sodium hypochlorite. World Allergy Organ J 2009;2:296-302.
115. Frew AJ. Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party. BMJ 1993;307:919-23.
116. Kaad PH, Ostergaard PA. The hazard of mould hyposensitization in children with asthma. Clin Allergy 1982;12:317-20.
117. Ostergaard PA, Kaad PH, Kristensen T. A prospective study on the safety of immunotherapy in children with severe asthma. Allergy 1986;41:588-93.
118. Martorell A, Sole A, Diez LV, Belenguer J, Sanz J, Torro M. Inmunoterapia en alergia a hongos. Rev Esp Alergol Inmunol Clin 1986; 1:188-92.
119. Tabar AI, Lizaso MT, García BE, Echechipía S, Olaguibel JM, Rodríguez A. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma. J Investig Allergol Clin Immunol 2000;10:327-33.
120. Moreno C, Fernández Távora L, Justicia JL, Cabeza N, Vidal C. Investigation of an adequate immunotherapy induction schedule with an Alternaria tenuis extract. Alergol Inmunol Clin 2001;16: 133-7.
121. Martínez-Cañavate A, Eseverri JL, Ródenas R, Tabar AI, Gardee J, Torres J, et al. Evaluation of paediatric tolerance to an extract of Alternaria alternata under two treatment regimes. A multicentre study. Allergol Immunopathol (Madr) 2005;33:138-41.
122. Dreborg S, Agrell B, Foucard T, Kjellman NI, Koivikko A, Nilsson S. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986;41:131-40.
123. Karlsson R, Agrell B, Dreborg S, Foucard T, Kjellman NI, Koivikko A, et al. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. II. In vitro results. Allergy 1986;41:141-50.
124. Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 1986;41:507-19.
125. Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. VI. IgE-mediated parameters during a one-year placebo-controlled study of immunotherapy with Cladosporium. Allergy 1987;42:305-14.
126. Malling HJ, Djurup R. Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium. Allergy 1988;43:60-70.
127. Malling HJ, Stahl Skov P. Diagnosis and immunotherapy of mould allergy. VIII. Qualitative and quantitative estimation of IgE in Cladosporium immunotherapy. Allergy 1988;43:228-38.
128. Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990;85:460-72.
129. Criado Molina A, Guerra Pasadas F, Daza Muñoz JC, Moreno Aguilar C, Almeda Llamas E, Muñoz Gomariz E, et al. Immunotherapy with an oral Alternaria extract in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters. Allergol Immunopathol (Madr) 2002;30:319-30.
130. Lizaso MT, Martínez A, Asturias JA, Algorta J, Madariaga B, Labarta N, et al. Biological standardization and maximum tolerated dose estimation of an Alternaria alternata allergenic extract. J Investig Allergol Clin Immunol 2006;16:94-103.
131. Tabar AI, Lizaso MT, García BE, Gómez B, Echechipía S, Aldunate MT, et al. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. Pediatr Allergy Immunol 2008;19:67-75.
132. Lizaso MT, Tabar AI, García BE, Gómez B, Algorta J, Asturias JA, et al. Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters. Pediatr Allergy Immunol 2008;19:76-81.
133. Kuna P, Kaczmarek J, Kupczyk M. Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children. J Allergy Clin Immunol 2011;127:502-8.e1-6.
134. Cantani A, Businco E, Maglio A. Alternaria allergy: a three-year controlled study in children treated with immunotherapy. Allergol Immunopathol (Madr) 1988;16:1-4.
135. Kiliç M, Altintas DU, Yilmaz M, Bingöl-Karakoç G, Burgut R, Güneser-Kendirli S. Evaluation of efficacy of immunotherapy in children with asthma monosensitized to Alternaria. Turk J Pediatr 2011;53:285-94.
136. Valenta R. The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2002;2:446-53.
137. Linhart B, Valenta R. Vaccines for allergy. Curr Opin Immunol 2012;24:354-60.
138. Linhart B, Valenta R. Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives. Vaccine 2012;30:4328-35.
139. Haselden BM, Kay AB, Larché M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999;189: 1885-94.
140. Oldfield WL, Kay AB, Larché M. Allergen-derived T cell peptide induced late asthmatic reactions precede the induction of antigenspecific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol 2001;167:1734-9.
141. Focke-Tejkl M, Valenta R. Safety of engineered allergen-specific immunotherapy vaccines. Curr Opin Allergy Clin Immunol 2012; 12:555-63.
142. Focke M, Mahler V, Ball T, Sperr WR, Majlesi Y, Valent P, et al. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J 2001;15:2042-4.
143. Focke M, Linhart B, Hartl A, Wiedermann U, Sperr WR, Valent P, et al. Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination. Clin Exp Allergy 2004;34:1525-33.
144. Edlmayr J, Niespodziana K, Linhart B, Focke-Tejkl M, Westritschnig K, Scheiblhofer S, et al. A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. J Immunol 2009;182:6298-306.
145. Zhang L, Curran IH, Muradia G, De Vouge MW, Rode H, Vijay HM. N-terminus of a major allergen, Alt a I, of Alternaria alternata defined to be an epitope. Int Arch Allergy Immunol 1995;108:254-9.
146. Kurup VP, Vijay HM, Kumar V, Castillo L, Elms N. IgE binding synthetic peptides of Alt a 1, a major allergen of Alternaria alternata. Peptides 2003;24:179-85.
147. Lai HY, Tam MF, Chou H, Lee SS, Tai HY, Shen HD. Molecular and structural analysis of immunoglobulin E-binding epitopes of Pen ch 13, an alkaline serine protease major allergen from Penicillium chrysogenum. Clin Exp Allergy 2004;34:1926-33.
148. Yu CJ, Chen YM, Su SN, Forouhar F, Lee SH, Chow LP. Molecular and immunological characterization and IgE epitope mapping of Pen n 18, a major allergen of Penicillium notatum. Biochem J 2002;363:707-15.
149. Banerjee B, Greenberger PA, Fink JN, Kurup VP. Conformational and linear B-cell epitopes of Asp f 2, a major allergen of Aspergillus fumigatus, bind differently to immunoglobulin E antibody in the sera of allergic bronchopulmonary aspergillosis patients. Infect Immun 1999;67:2284-91.
150. Vilhelmsson M, Glaser AG, Martinez DB, Schmidt M, Johansson C, Rhyner C, et al. Mutational analysis of amino acid residues involved in IgE-binding to the Malassezia sympodialis allergen Mala s 11. Mol Immunol 2008;46:294-303.
151. Cheng TT, Tam MF, Chou H, Tai HY, Shen HD. Lys89, Lys90, and Phe91 are critical core amino acid residues of the Pen ch 18 major fungal allergen recognized by human IgE antibodies. Biochem Biophys Res Commun 2008;375:671-4.
152. Shankar J, Singh BP, Gaur SN, Arora N. Engineered Alt a 13 fragment of Alternaria alternata abrogated IgE binding without affecting T-cell stimulation. J Clin Immunol 2009;29:63-70.